Vaccination Challenges in Rheumatic Diseases

This chapter explores how disease-modifying immunosuppressive drugs (DMIDs) impact vaccine responses in patients with rheumatic diseases, particularly highlighting poor immunogenic responses to common vaccines. It also examines Mixed Connective Tissue Disease (MCTD) as a distinct autoimmune condition, stressing the importance of accurate diagnosis and classification for effective treatment.